JUAN
SANCHIS FORES
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Miguel Servet
Zaragoza, EspañaHospital Miguel Servet -ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2023
-
Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 548-554
2022
-
Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study
Journal of Geriatric Cardiology, Vol. 19, Núm. 5, pp. 354-366
2020
-
Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
Open Heart, Vol. 7, Núm. 2
-
Efectos de la pandemia de COVID-19 sobre la población mayor de 75 años con revascularización coronaria previa: Subanálisis del registro EPIC SIERRA 75
REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 321-322
-
Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14
2015
-
Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2
Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 838-845
2010
-
Thrombosis of second-generation drug-eluting stents in real practice: Results from the multicenter Spanish registry ESTROFA-2 (estudio espaol sobre trombosis de stents farmacoactivos de segunda generacion-2)
JACC: Cardiovascular Interventions, Vol. 3, Núm. 9, pp. 911-919
2008
-
Drug-Eluting Stent Thrombosis. Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
Journal of the American College of Cardiology, Vol. 51, Núm. 10, pp. 986-990